Antiparasitic Drugs Market - Global Outlook and Forecast 2024-2031

Report ID: 1366284 | Published Date: Sep 2024 | No. of Page: 102 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Antiparasitic Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Antiparasitic Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Antiparasitic Drugs Overall Market Size
    2.1 Global Antiparasitic Drugs Market Size: 2021 VS 2028
    2.2 Global Antiparasitic Drugs Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Antiparasitic Drugs Players in Global Market
    3.2 Top Global Antiparasitic Drugs Companies Ranked by Revenue
    3.3 Global Antiparasitic Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Antiparasitic Drugs Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Antiparasitic Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Antiparasitic Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Antiparasitic Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Antiparasitic Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Antiparasitic Drugs Market Size Markets, 2021 & 2028
        4.1.2 Anthelmintics
        4.1.3 Antiprotozoals
        4.1.4 Others
    4.2 By Type - Global Antiparasitic Drugs Revenue & Forecasts
        4.2.1 By Type - Global Antiparasitic Drugs Revenue, 2017-2022
        4.2.2 By Type - Global Antiparasitic Drugs Revenue, 2023-2028
        4.2.3 By Type - Global Antiparasitic Drugs Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Antiparasitic Drugs Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Clinic
        5.1.4 Others
    5.2 By Application - Global Antiparasitic Drugs Revenue & Forecasts
        5.2.1 By Application - Global Antiparasitic Drugs Revenue, 2017-2022
        5.2.2 By Application - Global Antiparasitic Drugs Revenue, 2023-2028
        5.2.3 By Application - Global Antiparasitic Drugs Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Antiparasitic Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Antiparasitic Drugs Revenue & Forecasts
        6.2.1 By Region - Global Antiparasitic Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Antiparasitic Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Antiparasitic Drugs Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Antiparasitic Drugs Revenue, 2017-2028
        6.3.2 US Antiparasitic Drugs Market Size, 2017-2028
        6.3.3 Canada Antiparasitic Drugs Market Size, 2017-2028
        6.3.4 Mexico Antiparasitic Drugs Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Antiparasitic Drugs Revenue, 2017-2028
        6.4.2 Germany Antiparasitic Drugs Market Size, 2017-2028
        6.4.3 France Antiparasitic Drugs Market Size, 2017-2028
        6.4.4 U.K. Antiparasitic Drugs Market Size, 2017-2028
        6.4.5 Italy Antiparasitic Drugs Market Size, 2017-2028
        6.4.6 Russia Antiparasitic Drugs Market Size, 2017-2028
        6.4.7 Nordic Countries Antiparasitic Drugs Market Size, 2017-2028
        6.4.8 Benelux Antiparasitic Drugs Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Antiparasitic Drugs Revenue, 2017-2028
        6.5.2 China Antiparasitic Drugs Market Size, 2017-2028
        6.5.3 Japan Antiparasitic Drugs Market Size, 2017-2028
        6.5.4 South Korea Antiparasitic Drugs Market Size, 2017-2028
        6.5.5 Southeast Asia Antiparasitic Drugs Market Size, 2017-2028
        6.5.6 India Antiparasitic Drugs Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Antiparasitic Drugs Revenue, 2017-2028
        6.6.2 Brazil Antiparasitic Drugs Market Size, 2017-2028
        6.6.3 Argentina Antiparasitic Drugs Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Antiparasitic Drugs Revenue, 2017-2028
        6.7.2 Turkey Antiparasitic Drugs Market Size, 2017-2028
        6.7.3 Israel Antiparasitic Drugs Market Size, 2017-2028
        6.7.4 Saudi Arabia Antiparasitic Drugs Market Size, 2017-2028
        6.7.5 UAE Antiparasitic Drugs Market Size, 2017-2028
7 Players Profiles
    7.1 Ipca Laboratories Ltd
        7.1.1 Ipca Laboratories Ltd Corporate Summary
        7.1.2 Ipca Laboratories Ltd Business Overview
        7.1.3 Ipca Laboratories Ltd Antiparasitic Drugs Major Product Offerings
        7.1.4 Ipca Laboratories Ltd Antiparasitic Drugs Revenue in Global Market (2017-2022)
        7.1.5 Ipca Laboratories Ltd Key News
    7.2 Zydus Cadila
        7.2.1 Zydus Cadila Corporate Summary
        7.2.2 Zydus Cadila Business Overview
        7.2.3 Zydus Cadila Antiparasitic Drugs Major Product Offerings
        7.2.4 Zydus Cadila Antiparasitic Drugs Revenue in Global Market (2017-2022)
        7.2.5 Zydus Cadila Key News
    7.3 Merck
        7.3.1 Merck Corporate Summary
        7.3.2 Merck Business Overview
        7.3.3 Merck Antiparasitic Drugs Major Product Offerings
        7.3.4 Merck Antiparasitic Drugs Revenue in Global Market (2017-2022)
        7.3.5 Merck Key News
    7.4 Pfizer
        7.4.1 Pfizer Corporate Summary
        7.4.2 Pfizer Business Overview
        7.4.3 Pfizer Antiparasitic Drugs Major Product Offerings
        7.4.4 Pfizer Antiparasitic Drugs Revenue in Global Market (2017-2022)
        7.4.5 Pfizer Key News
    7.5 GlaxoSmithKline Plc.
        7.5.1 GlaxoSmithKline Plc. Corporate Summary
        7.5.2 GlaxoSmithKline Plc. Business Overview
        7.5.3 GlaxoSmithKline Plc. Antiparasitic Drugs Major Product Offerings
        7.5.4 GlaxoSmithKline Plc. Antiparasitic Drugs Revenue in Global Market (2017-2022)
        7.5.5 GlaxoSmithKline Plc. Key News
    7.6 Cipla Ltd
        7.6.1 Cipla Ltd Corporate Summary
        7.6.2 Cipla Ltd Business Overview
        7.6.3 Cipla Ltd Antiparasitic Drugs Major Product Offerings
        7.6.4 Cipla Ltd Antiparasitic Drugs Revenue in Global Market (2017-2022)
        7.6.5 Cipla Ltd Key News
    7.7 Ranbaxy Laboratories
        7.7.1 Ranbaxy Laboratories Corporate Summary
        7.7.2 Ranbaxy Laboratories Business Overview
        7.7.3 Ranbaxy Laboratories Antiparasitic Drugs Major Product Offerings
        7.7.4 Ranbaxy Laboratories Antiparasitic Drugs Revenue in Global Market (2017-2022)
        7.7.5 Ranbaxy Laboratories Key News
    7.8 Novartis AG
        7.8.1 Novartis AG Corporate Summary
        7.8.2 Novartis AG Business Overview
        7.8.3 Novartis AG Antiparasitic Drugs Major Product Offerings
        7.8.4 Novartis AG Antiparasitic Drugs Revenue in Global Market (2017-2022)
        7.8.5 Novartis AG Key News
    7.9 Alvizia Health Care
        7.9.1 Alvizia Health Care Corporate Summary
        7.9.2 Alvizia Health Care Business Overview
        7.9.3 Alvizia Health Care Antiparasitic Drugs Major Product Offerings
        7.9.4 Alvizia Health Care Antiparasitic Drugs Revenue in Global Market (2017-2022)
        7.9.5 Alvizia Health Care Key News
    7.10 Bayer AG
        7.10.1 Bayer AG Corporate Summary
        7.10.2 Bayer AG Business Overview
        7.10.3 Bayer AG Antiparasitic Drugs Major Product Offerings
        7.10.4 Bayer AG Antiparasitic Drugs Revenue in Global Market (2017-2022)
        7.10.5 Bayer AG Key News
    7.11 Roche Inc
        7.11.1 Roche Inc Corporate Summary
        7.11.2 Roche Inc Business Overview
        7.11.3 Roche Inc Antiparasitic Drugs Major Product Offerings
        7.11.4 Roche Inc Antiparasitic Drugs Revenue in Global Market (2017-2022)
        7.11.5 Roche Inc Key News
    7.12 Arbor Pharmaceuticals Inc.
        7.12.1 Arbor Pharmaceuticals Inc. Corporate Summary
        7.12.2 Arbor Pharmaceuticals Inc. Business Overview
        7.12.3 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Major Product Offerings
        7.12.4 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Revenue in Global Market (2017-2022)
        7.12.5 Arbor Pharmaceuticals Inc. Key News
    7.13 Sanofi
        7.13.1 Sanofi Corporate Summary
        7.13.2 Sanofi Business Overview
        7.13.3 Sanofi Antiparasitic Drugs Major Product Offerings
        7.13.4 Sanofi Antiparasitic Drugs Revenue in Global Market (2017-2022)
        7.13.5 Sanofi Key News
    7.14 AstraZeneca
        7.14.1 AstraZeneca Corporate Summary
        7.14.2 AstraZeneca Business Overview
        7.14.3 AstraZeneca Antiparasitic Drugs Major Product Offerings
        7.14.4 AstraZeneca Antiparasitic Drugs Revenue in Global Market (2017-2022)
        7.14.5 AstraZeneca Key News
    7.15 Alkem Laboratories Limited
        7.15.1 Alkem Laboratories Limited Corporate Summary
        7.15.2 Alkem Laboratories Limited Business Overview
        7.15.3 Alkem Laboratories Limited Antiparasitic Drugs Major Product Offerings
        7.15.4 Alkem Laboratories Limited Antiparasitic Drugs Revenue in Global Market (2017-2022)
        7.15.5 Alkem Laboratories Limited Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. Antiparasitic Drugs Market Opportunities & Trends in Global Market
    Table 2. Antiparasitic Drugs Market Drivers in Global Market
    Table 3. Antiparasitic Drugs Market Restraints in Global Market
    Table 4. Key Players of Antiparasitic Drugs in Global Market
    Table 5. Top Antiparasitic Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Antiparasitic Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Antiparasitic Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Antiparasitic Drugs Product Type
    Table 9. List of Global Tier 1 Antiparasitic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Antiparasitic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Antiparasitic Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Antiparasitic Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Antiparasitic Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Antiparasitic Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Antiparasitic Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Antiparasitic Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Antiparasitic Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Antiparasitic Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Antiparasitic Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Antiparasitic Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Antiparasitic Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Antiparasitic Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Antiparasitic Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Antiparasitic Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Antiparasitic Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Antiparasitic Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Antiparasitic Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Antiparasitic Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Antiparasitic Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. Ipca Laboratories Ltd Corporate Summary
    Table 31. Ipca Laboratories Ltd Antiparasitic Drugs Product Offerings
    Table 32. Ipca Laboratories Ltd Antiparasitic Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Zydus Cadila Corporate Summary
    Table 34. Zydus Cadila Antiparasitic Drugs Product Offerings
    Table 35. Zydus Cadila Antiparasitic Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Merck Corporate Summary
    Table 37. Merck Antiparasitic Drugs Product Offerings
    Table 38. Merck Antiparasitic Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Pfizer Corporate Summary
    Table 40. Pfizer Antiparasitic Drugs Product Offerings
    Table 41. Pfizer Antiparasitic Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. GlaxoSmithKline Plc. Corporate Summary
    Table 43. GlaxoSmithKline Plc. Antiparasitic Drugs Product Offerings
    Table 44. GlaxoSmithKline Plc. Antiparasitic Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. Cipla Ltd Corporate Summary
    Table 46. Cipla Ltd Antiparasitic Drugs Product Offerings
    Table 47. Cipla Ltd Antiparasitic Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. Ranbaxy Laboratories Corporate Summary
    Table 49. Ranbaxy Laboratories Antiparasitic Drugs Product Offerings
    Table 50. Ranbaxy Laboratories Antiparasitic Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. Novartis AG Corporate Summary
    Table 52. Novartis AG Antiparasitic Drugs Product Offerings
    Table 53. Novartis AG Antiparasitic Drugs Revenue (US$, Mn), (2017-2022)
    Table 54. Alvizia Health Care Corporate Summary
    Table 55. Alvizia Health Care Antiparasitic Drugs Product Offerings
    Table 56. Alvizia Health Care Antiparasitic Drugs Revenue (US$, Mn), (2017-2022)
    Table 57. Bayer AG Corporate Summary
    Table 58. Bayer AG Antiparasitic Drugs Product Offerings
    Table 59. Bayer AG Antiparasitic Drugs Revenue (US$, Mn), (2017-2022)
    Table 60. Roche Inc Corporate Summary
    Table 61. Roche Inc Antiparasitic Drugs Product Offerings
    Table 62. Roche Inc Antiparasitic Drugs Revenue (US$, Mn), (2017-2022)
    Table 63. Arbor Pharmaceuticals Inc. Corporate Summary
    Table 64. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Product Offerings
    Table 65. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Revenue (US$, Mn), (2017-2022)
    Table 66. Sanofi Corporate Summary
    Table 67. Sanofi Antiparasitic Drugs Product Offerings
    Table 68. Sanofi Antiparasitic Drugs Revenue (US$, Mn), (2017-2022)
    Table 69. AstraZeneca Corporate Summary
    Table 70. AstraZeneca Antiparasitic Drugs Product Offerings
    Table 71. AstraZeneca Antiparasitic Drugs Revenue (US$, Mn), (2017-2022)
    Table 72. Alkem Laboratories Limited Corporate Summary
    Table 73. Alkem Laboratories Limited Antiparasitic Drugs Product Offerings
    Table 74. Alkem Laboratories Limited Antiparasitic Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Antiparasitic Drugs Segment by Type in 2021
    Figure 2. Antiparasitic Drugs Segment by Application in 2021
    Figure 3. Global Antiparasitic Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Antiparasitic Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Antiparasitic Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Antiparasitic Drugs Revenue in 2021
    Figure 8. By Type - Global Antiparasitic Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Antiparasitic Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Antiparasitic Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Antiparasitic Drugs Revenue Market Share, 2017-2028
    Figure 12. US Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Antiparasitic Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Antiparasitic Drugs Revenue Market Share, 2017-2028
    Figure 24. China Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Antiparasitic Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Antiparasitic Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Antiparasitic Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. Ipca Laboratories Ltd Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Zydus Cadila Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Merck Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Pfizer Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. GlaxoSmithKline Plc. Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Cipla Ltd Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Ranbaxy Laboratories Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Novartis AG Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Alvizia Health Care Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Bayer AG Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Roche Inc Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Sanofi Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. AstraZeneca Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Alkem Laboratories Limited Antiparasitic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Antiparasitic Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Antiparasitic Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Antiparasitic Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports